Back
Deciphera Pharmaceuticals Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
70
DCPH
Deciphera Pharmaceuticals
Last Price:
25.47
Seasonality Move:
22.51%
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
41.30
Seasonality Move:
9.35%
Buy
70
Deciphera Pharmaceuticals (DCPH)
is a Buy
Is Deciphera Pharmaceuticals a Buy, Sell or Hold?
- The current Deciphera Pharmaceuticals [DCPH] share price is $25.46. The Score for DCPH is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- DCPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $41.31. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DCPH Stock Price Chart
What is Deciphera Pharmaceuticals's stock price today?
-
The Deciphera Pharmaceuticals share price today is $25.46
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DCPH is experiencing slight buying pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $41.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
DCPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.42 | Buy |
Relative Strength Index (14 RSI): | 85.97 | Buy |
Chaikin Money Flow: | 384294 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.79 - 26.35) | Buy |
Bollinger Bands (100): | (13.17 - 20.51) | Buy |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.04 | Sell |
Relative Strength Index (14 RSI): | 34.23 | Sell |
Chaikin Money Flow: | -659109 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.82 - 49.38) | Sell |
Bollinger Bands (100): | (49.98 - 66.92) | Sell |
DCPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.42 | Buy |
20-day SMA: | 22.67 | Buy |
50-day SMA: | 18.3 | Buy |
200-day SMA: | 14.97 | Buy |
8-day EMA: | 25.18 | Buy |
20-day EMA: | 23.06 | Buy |
50-day EMA: | 19.77 | Buy |
200-day EMA: | 16.15 | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.04 | Sell |
20-day SMA: | 45.31 | Sell |
50-day SMA: | 51.48 | Sell |
200-day SMA: | 51.74 | Sell |
8-day EMA: | 42.54 | Sell |
20-day EMA: | 45.19 | Sell |
50-day EMA: | 50.4 | Sell |
200-day EMA: | 55.58 | Sell |
Deciphera Pharmaceuticals Earnings Growth & DCPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.01 per share, an increase this year of $0.24 per share, and an increase next year of $0.41 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.88 per share, an increase next quarter of $0.34 per share, an increase this year of $3.60 per share, and an increase next year of $2.16 per share.
Deciphera Pharmaceuticals Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |